AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...

EDT Cathie Wood’s ARK Investment buys 255K shares of Cerus (CERS) today Published first on TheFly – the ultimate source for ...

On Friday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.7 which represents a slight increase of $0.07 or 4.29% from the prior close of $1.63. The stock opened at $1.63 and touched ...

As tensions with Tehran escalate, Alma Center pundits urge drying up the supply of weapons to Shiite terror group; warn that ...

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Cerus (CERS – Research Report). The ...

Cerus (NASDAQ:CERS – Free Report) had its target price trimmed by Stifel Nicolaus from $6.00 to $3.00 in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has a buy ...

On Monday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.89 which represents a slight increase of $0.07 or 3.85% from the prior close of $1.82. The stock opened at $1.91 and ...

Product Revenue: $45.1 million in Q2 2024, a 16% year-over-year growth. First Half Revenue: $83.4 million, up 20% from the first half of last year. North American Platelet Sales Growth: 19% ...

Nurix Therapeutics’ BTK degrader has elicited responses in a small group of patients with certain cancers, supporting the ...

IFC Revenue Guidance: Expected to be in the range of $8 million to $10 million for full year 2024. Cerus Corp (NASDAQ:CERS) raised its annual product revenue guidance to $175 million to $178 million, ...

The AEMC has opened a new consultation exploring the use of smart data to optimise consumer energy resources such as solar PV ...